IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 256 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $203,989 | -72.5% | 25,435 | -49.2% | 0.00% | -66.7% |
Q1 2024 | $741,356 | +157.1% | 50,024 | +41.0% | 0.00% | +200.0% |
Q4 2023 | $288,355 | +1702.2% | 35,468 | +2306.2% | 0.00% | – |
Q2 2022 | $16,000 | -46.7% | 1,474 | -18.7% | 0.00% | – |
Q1 2022 | $30,000 | +20.0% | 1,814 | +37.6% | 0.00% | – |
Q4 2021 | $25,000 | -26.5% | 1,318 | -5.8% | 0.00% | – |
Q3 2021 | $34,000 | +21.4% | 1,399 | +32.0% | 0.00% | – |
Q2 2021 | $28,000 | -9.7% | 1,060 | +8.3% | 0.00% | – |
Q1 2021 | $31,000 | -3.1% | 979 | +39.9% | 0.00% | – |
Q4 2020 | $32,000 | +33.3% | 700 | 0.0% | 0.00% | – |
Q3 2020 | $24,000 | +20.0% | 700 | 0.0% | 0.00% | – |
Q2 2020 | $20,000 | – | 700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MHR Fund Management | 19,997,103 | $90,986,819 | 11.15% |
MPM BioImpact LLC | 3,287,397 | $14,957,656 | 3.99% |
Perceptive Advisors | 11,962,938 | $54,431,367 | 1.82% |
CM Management, LLC | 200,000 | $910,000 | 0.97% |
Velan Capital Investment Management LP | 250,000 | $1,137,500 | 0.92% |
Opaleye Management Inc. | 610,000 | $2,775,500 | 0.90% |
Boxer Capital, LLC | 3,705,133 | $16,858,355 | 0.90% |
SECTORAL ASSET MANAGEMENT INC | 985,000 | $4,481,750 | 0.87% |
Parametrica Management Ltd | 95,400 | $434,070 | 0.73% |
683 Capital Management, LLC | 2,050,000 | $9,327,501 | 0.72% |